Stanford Mwasongwe1, Yan Gao2, Michael Griswold3, James G Wilson2, Abraham Aviv4, Alexander P Reiner5, Laura M Raffield6. 1. Jackson Heart Study, School of Public Health, Jackson State University, Jackson, MS, USA. 2. Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA. 3. Department of Data Science, John D Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS, USA. 4. Center of Human Development and Aging, New Jersey Medical School, Rutgers, Newark, NJ, USA. 5. Department of Epidemiology, University of Washington, Seattle, WA, USA. 6. Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: laura_raffield@unc.edu.
Abstract
BACKGROUND AND AIMS: In European descent populations, shorter leukocyte telomere length (LTL) has been associated with subclinical atherosclerosis, cardiovascular disease (CVD), and mortality, while longer LTL has been associated with greater left ventricular hypertrophy. We evaluated the relationship of LTL with subclinical cardiovascular disease indices and incident clinical events and mortality in African Americans (AAs). METHODS: Analyses were restricted to 2518 participants of the Jackson Heart Study (JHS) with LTL measured by Southern blot in baseline blood samples. RESULTS: Adjusting for established CVD risk factors, longer LTL was significantly associated with lower prevalence of coronary artery calcification (CAC) (odds ratio (OR) = 0.810) per 1 kb increase in LTL; (95% confidence interval [CI] 0.656, 0.9998), p=0.0498). Longer LTL was also associated with higher ankle brachial index (ABI) (β = 0.023; (95% CI 0.004, 0.042), p=0.017) when comparing the highest to the lowest LTL quartile. There were no significant associations between LTL and abdominal aortic calcification, carotid intima-media thickness, or left ventricular mass. After a median follow-up of 9 years, longer LTL was associated with lower risk of incident ischemic stroke (hazard ratio (HR) 0.69 (95% CI 0.48, 0.99), p=0.044) and total mortality (HR 0.81 (95% CI 0.67, 0.97), p=0.026) in age and sex adjusted models, but these associations were no longer significant in fully adjusted models. CONCLUSIONS: Among a community-based cohort of AAs, longer LTL was nominally associated with lower odds of CAC and increased ABI, indicative of decreased prevalence of subclinical atherosclerosis and peripheral arterial disease. These findings do not offer strong support for LTL as an independent biomarker of CVD risk in AAs.
BACKGROUND AND AIMS: In European descent populations, shorter leukocyte telomere length (LTL) has been associated with subclinical atherosclerosis, cardiovascular disease (CVD), and mortality, while longer LTL has been associated with greater left ventricular hypertrophy. We evaluated the relationship of LTL with subclinical cardiovascular disease indices and incident clinical events and mortality in African Americans (AAs). METHODS: Analyses were restricted to 2518 participants of the Jackson Heart Study (JHS) with LTL measured by Southern blot in baseline blood samples. RESULTS: Adjusting for established CVD risk factors, longer LTL was significantly associated with lower prevalence of coronary artery calcification (CAC) (odds ratio (OR) = 0.810) per 1 kb increase in LTL; (95% confidence interval [CI] 0.656, 0.9998), p=0.0498). Longer LTL was also associated with higher ankle brachial index (ABI) (β = 0.023; (95% CI 0.004, 0.042), p=0.017) when comparing the highest to the lowest LTL quartile. There were no significant associations between LTL and abdominal aortic calcification, carotid intima-media thickness, or left ventricular mass. After a median follow-up of 9 years, longer LTL was associated with lower risk of incident ischemic stroke (hazard ratio (HR) 0.69 (95% CI 0.48, 0.99), p=0.044) and total mortality (HR 0.81 (95% CI 0.67, 0.97), p=0.026) in age and sex adjusted models, but these associations were no longer significant in fully adjusted models. CONCLUSIONS: Among a community-based cohort of AAs, longer LTL was nominally associated with lower odds of CAC and increased ABI, indicative of decreased prevalence of subclinical atherosclerosis and peripheral arterial disease. These findings do not offer strong support for LTL as an independent biomarker of CVD risk in AAs.
Authors: Myra A Carpenter; Richard Crow; Michael Steffes; William Rock; Jeffrey Heilbraun; Gregory Evans; Thomas Skelton; Robert Jensen; Daniel Sarpong Journal: Am J Med Sci Date: 2004-09 Impact factor: 2.378
Authors: Mariuca Vasa-Nicotera; Scott Brouilette; Massimo Mangino; John R Thompson; Peter Braund; Jenny-Rebecca Clemitson; Andrea Mason; Clare L Bodycote; Stuart M Raleigh; Edward Louis; Nilesh J Samani Journal: Am J Hum Genet Date: 2004-11-01 Impact factor: 11.025
Authors: J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano Journal: Radiology Date: 2005-01 Impact factor: 11.105
Authors: Christopher J O'Donnell; Serkalem Demissie; Masayuki Kimura; Daniel Levy; Jeffery P Gardner; Charles White; Ralph B D'Agostino; Philip A Wolf; Joseph Polak; L Adrienne Cupples; Abraham Aviv Journal: Arterioscler Thromb Vasc Biol Date: 2008-04-03 Impact factor: 8.311
Authors: Cara L Carty; Charles Kooperberg; Jingmin Liu; Megan Herndon; Themistocles Assimes; Lifang Hou; Candyce H Kroenke; Andrea Z LaCroix; Masayuki Kimura; Abraham Aviv; Alexander P Reiner Journal: Arterioscler Thromb Vasc Biol Date: 2015-08-06 Impact factor: 8.311
Authors: Simon L I J Denil; Ernst R Rietzschel; Marc L De Buyzere; Caroline M Van Daele; Patrick Segers; Dirk De Bacquer; Wim Van Criekinge; Sofie Bekaert; Thierry C Gillebert; Tim De Meyer Journal: PLoS One Date: 2014-12-15 Impact factor: 3.240
Authors: Margaret A Taub; Matthew P Conomos; Rebecca Keener; Kruthika R Iyer; Joshua S Weinstock; Lisa R Yanek; John Lane; Tyne W Miller-Fleming; Jennifer A Brody; Laura M Raffield; Caitlin P McHugh; Deepti Jain; Stephanie M Gogarten; Cecelia A Laurie; Ali Keramati; Marios Arvanitis; Albert V Smith; Benjamin Heavner; Lucas Barwick; Lewis C Becker; Joshua C Bis; John Blangero; Eugene R Bleecker; Esteban G Burchard; Juan C Celedón; Yen Pei C Chang; Brian Custer; Dawood Darbar; Lisa de Las Fuentes; Dawn L DeMeo; Barry I Freedman; Melanie E Garrett; Mark T Gladwin; Susan R Heckbert; Bertha A Hidalgo; Marguerite R Irvin; Talat Islam; W Craig Johnson; Stefan Kaab; Lenore Launer; Jiwon Lee; Simin Liu; Arden Moscati; Kari E North; Patricia A Peyser; Nicholas Rafaels; Christine Seidman; Daniel E Weeks; Fayun Wen; Marsha M Wheeler; L Keoki Williams; Ivana V Yang; Wei Zhao; Stella Aslibekyan; Paul L Auer; Donald W Bowden; Brian E Cade; Zhanghua Chen; Michael H Cho; L Adrienne Cupples; Joanne E Curran; Michelle Daya; Ranjan Deka; Celeste Eng; Tasha E Fingerlin; Xiuqing Guo; Lifang Hou; Shih-Jen Hwang; Jill M Johnsen; Eimear E Kenny; Albert M Levin; Chunyu Liu; Ryan L Minster; Take Naseri; Mehdi Nouraie; Muagututi'a Sefuiva Reupena; Ester C Sabino; Jennifer A Smith; Nicholas L Smith; Jessica Lasky Su; James G Taylor; Marilyn J Telen; Hemant K Tiwari; Russell P Tracy; Marquitta J White; Yingze Zhang; Kerri L Wiggins; Scott T Weiss; Ramachandran S Vasan; Kent D Taylor; Moritz F Sinner; Edwin K Silverman; M Benjamin Shoemaker; Wayne H-H Sheu; Frank Sciurba; David A Schwartz; Jerome I Rotter; Daniel Roden; Susan Redline; Benjamin A Raby; Bruce M Psaty; Juan M Peralta; Nicholette D Palmer; Sergei Nekhai; Courtney G Montgomery; Braxton D Mitchell; Deborah A Meyers; Stephen T McGarvey; Angel Cy Mak; Ruth Jf Loos; Rajesh Kumar; Charles Kooperberg; Barbara A Konkle; Shannon Kelly; Sharon Lr Kardia; Robert Kaplan; Jiang He; Hongsheng Gui; Frank D Gilliland; Bruce D Gelb; Myriam Fornage; Patrick T Ellinor; Mariza de Andrade; Adolfo Correa; Yii-Der Ida Chen; Eric Boerwinkle; Kathleen C Barnes; Allison E Ashley-Koch; Donna K Arnett; Cathy C Laurie; Goncalo Abecasis; Deborah A Nickerson; James G Wilson; Stephen S Rich; Daniel Levy; Ingo Ruczinski; Abraham Aviv; Thomas W Blackwell; Timothy Thornton; Jeff O'Connell; Nancy J Cox; James A Perry; Mary Armanios; Alexis Battle; Nathan Pankratz; Alexander P Reiner; Rasika A Mathias Journal: Cell Genom Date: 2022-01-13
Authors: Jennifer A Smith; Jeremy Raisky; Scott M Ratliff; Jiaxuan Liu; Sharon L R Kardia; Stephen T Turner; Thomas H Mosley; Wei Zhao Journal: BMC Med Genomics Date: 2019-10-22 Impact factor: 3.063
Authors: Stanford E Mwasongwe; Tibor Fülöp; Ronit Katz; Solomon K Musani; Mario Sims; Adolfo Correa; Michael F Flessner; Bessie A Young Journal: J Clin Hypertens (Greenwich) Date: 2018-02-16 Impact factor: 3.738
Authors: LáShauntá M Glover; Crystal W Cené; Alexander Reiner; Samson Gebreab; David R Williams; Kari E North; Mario Sims Journal: Healthcare (Basel) Date: 2021-05-28